Stem Cell Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q3 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Stem Cell Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q3 2023.
  • Stem Cell Inc. Debt-to-equity for the quarter ending September 30, 2023 was -117 %, a 144% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2023 -117 -382 -144% Sep 30, 2023
Q2 2023 -242 -78.5 -47.9% Jun 30, 2023
Q1 2023 -331 -178 -116% Mar 31, 2023
Q4 2022 -1.53K -1.4K -1055% Dec 31, 2022
Q3 2022 265 +381 Sep 30, 2022
Q2 2022 -164 Jun 30, 2022
Q1 2022 -153 Mar 31, 2022
Q4 2021 -133 Dec 31, 2021
Q3 2021 -116 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.